Burkholderia cepacia is an important pathogen that often causes pneumonia in immunocompromised individuals. Here, it was demonstrated that the TLR5 agonist flagellin could locally activate innate immunity. This was characterized by rapid expressions of IL-1β, TNF-α, and iNOS mRNA and a delay in the expression of IL-10 mRNA. A significant elevation in the IL-1β, TNF-α, and nitric oxide levels was also noted. In the respiratory tract, flagellin induced neutrophil infiltration into the airways, which was observed by histopathological examination and confirmed by the neutrophil count and level of myeloperoxidase activity. This was concomitant with a high activity of alveolar macrophages that engulfed and killed B. cepacia in vitro. The flagellin mucosal treatment improved the B. cepacia clearance in the mouse lung. Thus, the present findings illustrate the profound stimulatory effect of flagellin on the lung mucosal innate immunity, a response that needs to be exploited therapeutically to prevent the development of respiratory tract infection by B. cepacia.
The innate immune response represents the first line of defense in the case of infection. Toll-like receptors (TLRs) represent a major family of pattern recognition receptors (PRRs) playing a front-line role in host defenses by inducing innate immune responses through nuclear factor kappa B (NF-kB) signaling [38] as well as through members of the mitogen-activated protein kinase (MAPK) family [6, 46] . They also control the expression of multiple genes involved in inflammatory response, such as tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) [4] . Flagellin elicits immune responses upon binding to its receptor, TLR5 [13] , expressed by immune and various cells [2, 8, 10, 33] .
Alveolar macrophages (AMs) play a central role in response to pathogen through producing proinflammatory mediators such as proinflammatory cytokines and nitric oxide (NO), and increasing phagocytic activity [5] . Nitric oxide is generated by the inducible isoform of nitric oxide synthase (iNOS). NO has beneficial microbicidal, antiviral, antiparasital, immunomodulatory, and antitumoral effects [11] . The mucosal administration of flagellin is known to induce myeloid differentiation primary response gene 88 (MyD88)-dependent signaling, characterized by rapid and heavy neutrophil infiltration into the airways [2, 10, 19] . Neutrophils are important effector cells of the innate immune system (IIS) and can function as modulators between the IIS and the adaptive immune system (AIS). Neutrophils can be detected in tissue using two methods; the cell count and myeloperoxidase activity [9, 23, 40] .
Burkholderia cepacia is an opportunistic pathogen that can infect the respiratory tract of cystic fibrosis patients. It is also gaining recognition as a pathogen in nosocomial infections [7] and in patients who are immunodeficient, particularly those who have chronic granulomatous disease [3, 12] . B. cepacia is intrinsically resistant to many antibiotics making it difficult to eradicate [25] . Thus, the innate immune system is very important to clear B. cepacia from the airways [45] , which is why modulating the innate immune response to eradicate pathogens responsible for respiratory tract infections is a key imperative [22] .
Flagellin administration may provide a clinically useful approach to prevent infections in patients treated with broad-spectrum antibiotics. Kinnebrew et al. [22] proved that the systemic administration of flagellin to antibiotictreated mice dramatically reduced vancomycin-resistant enterococcus (VRE) colonization by enhancing mucosal resistance due to the development of innate immunity against multidrug-resistant organisms [22] . In another recent study, the intranasal pretreatment of mice with purified Pseudomonas aeruginosa flagellin led to strong protection against intratracheal P. aeruginosa-induced lethality, which was attributed to markedly improved bacterial clearance, reduced dissemination, and decreased alveolar permeability [41] . Muñoz et al. [28] also reported that flagellin treatment improved S. pneumoniae clearance in the lungs, leading to increased survival of the infected host.
The present study demonstrates the mucosal innate immunemediated protection provided by the prior intranasal instillation of flagellin.
MATERIAL AND METHODS

Bacterial Isolate
B. cepacia (ATCC25609) and Escherichia coli K-12 were used in this study. The bacteria were preserved by lyophilization and routinely cultured at 37 o C on Luria-Bertani agar plates. Subcultures were made every week.
Flagellin Preparation
Flagellin from E. coli K-12 was isolated and purified according to a procedure described earlier [43] . Lipopolysaccharide (LPS) was removed from the flagellin preparation by passing it through a polymyxin B column according to the manufacturer's instructions (Detoxin-Gel; Pierce, Rockford, IL, USA) and as described by others [27] .
Experiment
Test group: 16 mice were instilled with 1 µg of flagellin (E. coli K-12) (primary instillation) and then challenged after 4 h with 50 µl of B. cepacia (5 × 10 8 CFU/50 µl) via an intranasal route (secondary instillation). Four animals were sacrificed at different times post the bacterial infection.
Control group A (16 mice): The same protocol was followed as described for the test group, except that phosphate-buffered saline (PBS) was used for the primary instillation instead of flagellin.
Control group B (16 mice): The same protocol was followed as described for the test group, except that PBS was instilled intranasally after 4 h instead of B. cepacia.
Control group C (16 mice): These mice were administrated normal saline intranasally on both occasions.
The bacterial number (B. cepacia) (CFU/ml) in the lungs of the test and control animals was quantified at different time intervals, where four animals were sacrificed and lung tissues sampled to determine the bacterial numbers (CFU/ml) and quantify the inflammatory mediators and macrophage activity.
Proinflammatory and Anti-Inflammatory Mediators
The whole lungs were weighed and then homogenized in 3 ml of a lysis buffer containing 0.5% Triton X-100, 150 mM NaCl, 15 mM Tris, and 1 mM MgCl (pH 7.4) [26] .
Cytokines Assay
The TNF-α, IL-1β, and IL-10 levels were detected in lung homogenate supernatants from the test and control groups at different time intervals post the second instillation. Mouse enzymelinked immunosorbent assay kits were used to measure all the cytokines. IL-1β (BD OptEIA, San Jose, CA USA), IL-10, and TNF-α (ANTIGENIX AMERICA Inc., Hunting sta., New York, USA) kits were used according to the manufacturer's instructions.
Preparation of Total RNA and RT-PCR
The lungs were homogenized in a Trizol reagent (Invitrogen, CA, USA) using an Ultra Turrax homogenizer and stored at -80 o C. The total RNA was then isolated using an RNA isolation kit (Ultraspec-II; Biotecx, Houston, TX, USA). The TNF-α, IL-1β, IL-10, iNOS and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) mRNA levels were measured using a reverse transcription-polymerase chain reaction (RT-PCR) [18] . The purified total RNA was used as the template in the RT-PCR. The cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase (Promega) according to the manufacturer's instructions. The PCR primers used were as described previously for TNF-α, IL-1β, IL-10, iNOS, and G3PDH [17, 28, 37, 47] The amplified products were separated on 1.8% agarose gels, stained with ethidium bromide, and the band intensity was measured using a still video system (Eagle Eye II; Stratagene, La Jolla, CA, USA). The G3PDH mRNA expression was also included to indicate that the gene expression differences were not due to concentration differences of the total RNA templates. The results are expressed as the ratio of the mean count of the IL-1β, TNF-α, IL-10, and iNOS mRNA expression levels to that of the G3PDH mRNA expression level.
Myeloperoxidase (MPO)
The standard method of Hirano [15] was followed to check the MPO activity in the lung homogenates as an indirect measure of neutrophil infiltration.
Measurement of Nitric Oxide (NO) Production
To confirm the NO production in the lungs, the nitric oxide reaction was measured in terms of the nitrite level in the lung homogenate using the standard colorimetric method described earlier [39] .
Malondialdehyde (MDA)
MDA is a metabolite resulting from lipid peroxidation and was detected using the method of Ohkawa et al. [29] .
Protein Determination
The total protein content was estimated in the lung homogenate supernatants by the Folin-phenol method of Lowry et al. [24] .
Phagocytosis
Phagocytosis was performed according to the method of Zgair and Chhibber [42] . The bacteria were harvested and suspended in PBS (0.1 M, pH 7.2) to obtain the optical density corresponding to 10 5 CFU/ml. The alveolar macrophages were obtained according to the method described by Zgair and Chhibber [42] and then suspended in RPMI 1640 (High Media Laboratories Ltd., Mumbai). For the bacterial uptake, normal mouse serum, a macrophage cell suspension (10 4 cell/ml), and bacterial suspension (10 5 CFU/ml) were vortexed and incubated at 37 o C under a 5% CO 2 atmosphere. Aliquots were taken regularly after 0, 30, and 60 min of incubation and centrifuged. The viable count of bacteria in the supernatant was determined by plating appropriate serial dilutions on nutrient agar plates. The results were expressed as the viable bacteria (CFU/ml) taken up by the macrophages at the respective sampling time. For intracellular killing, the bacterial suspension (10 5 CFU/ml) was mixed with normal mouse serum and kept for 30 min at 37 o C. Next, macrophages (10 4 cell/ml) were added to the bacterial suspension, incubated, and centrifuged. The cells were then lysed at different time intervals (0, 1, 2, and 3 h). The bacterial colonies were counted after overnight incubation at 37 o C and are expressed as CFU/ml.
Branchoalveolar Lavage Cell Counts
The total cell count in the bronchoalveolar lavage (BAL) specimens was measured using a hemocytometer. The differential cells count was determined by examining a stained smear using a Leishman stain [36] .
Statistical Analysis
All values are the mean value and standard error calculated. The differences were analyzed using the Student's t test employing Origin 8.0 version software. A value of P<0.05 was considered to be statistically significant.
RESULTS
E. coli Flagellin Purification
Flagella were separated from E. coli K-12 using differential centrifugation, as described in the Materials and Methods section. The flagella were converted from a polymeric protein to a monomeric protein by heating the flagellar filament suspension. The flagellin purity was checked by SDS-PAGE following staining with Coomassie blue. Fig. 1 shows the purity of the protein preparation (Lane B). The molecular mass of the protein was calculated to be 60 kDa.
Proinflammatory and Anti-Inflammatory Cytokine Levels
The time course of changes in IL-1β production in the lung homogenates from the mice immunized intranasally with flagellin before B. cepacia infection was estimated ( Fig. 2A) . The maximum level of IL-1β was seen as early as 4 h post bacterial infection in the test group and this increase was significantly high (P<0.005) when compared with the other control groups (A, B, and C). However, the IL-1β level declined gradually with time and no significant difference was observed on the third day post bacterial infection. Fig. 2B shows the results of the TNF-α level in the lung homogenates of the test and other control groups. Significant production of TNF-α was observed as early as 4 h post bacterial infection when compared with all the control groups (A, B, and C). However, at 72 h, the levels of TNF-α in the test group were similar to those in the control groups (B and C). A significant elevation in of IL-10 generation occurred as early as 24 h post bacteria instillation when compared with all the control groups (A, B, and C), and the maximum level was observed at 72 h (Fig. 2C) .
IL-1β, TNF-α, and IL-10 mRNA Expressions
To assess the time course of changes in the mRNA of IL-1β, TNF-α, and IL-10 expressions, an RT-PCR analysis of the total lung homogenates was conducted. The RNA was isolated at different time intervals after the second instillation. For a semiquantitative evaluation, the IL-1β, TNF-α, and IL-10 expression levels were normalized against the expression level of the housekeeping gene GA3DH (Fig. 3) . IL-1β and TNF-α were both significantly expressed after 1 h, with the maximum observation at 4 h post the second instillation in the test and control groups (A and B) . The highest expression of these genes was observed in the test group when compared with the control groups (A, B, and C) at each time point: 1 h, 2 h, and 4 h after the second instillation (Fig. 3A, 3B, 3D, and 3E ). Significant expression of IL-10 mRNA was seen at 16 h after the second instillation in the test and control groups A and B when compared with control group C. The maximum expression of this gene was found in control group B, followed by the test group, while the minimum was found in control group A (Fig. 3C and 3F ). Neutrophil Count, Levels of MPO Activity, MDA, and NO Concentration The neutrophil count in the BAL fluid (BALF) obtained from the test and control groups (A, B, and C) is shown in Fig. 4A. Fig. 4B represents the time course of MPO activity levels in the mouse lung homogenates from the test and control groups (A, B, and C). The level of MPO activity is normally used as an indicator of neutrophil infiltration in The maximum MPO activity and neutrophil infiltration were both observed 24 h post the second instillation and this was significant in the test group when compared with the control groups. A significant elevation of the MDA level was observed at 24 h, yet this was still lower than the MDA levels in control groups A and B. A significant increase in the NO concentration was observed at 4 h, with the maximum concentration at 24 h. Test group: black bars and solid line. the studied tissues. Similar results of MPO activity were found at 0 and 4 h after the second instillation, but transient elevation of neutrophil infiltration was seen at 4 h in the test and control groups (A and B). The maximum MPO activity level in the lung homogenates and maximum neutrophil count in the BALF for the test and control groups (A and B) were both observed at 24 h after the second instillation and decreased thereafter. The elevation of MPO activity and neutrophil infiltration in the test group was significant at 24 h post the second instillation when compared with all the control groups.
The lipid peroxidation was assessed on the basis of the MDA level. Fig. 4C shows the time course of changes in the MDA levels in the lung homogenates for the test and control groups. In this study, the instillation of flagellin before the bacterial infection (test group) resulted in less production of MDA when compared with that produced in the group infected with only bacteria (group A). This difference was significant at 24 and 72 h post the second instillation. In contrast the level of MDA in the test group was higher than that in the group of mice instilled with only PBS (group C) at the same time points (24 and 72 h). No significant difference was seen between the test group and control group B (mice administrated flagellin only) at any of the time points. Therefore, these results show that the administration of flagellin before bacterial infection led to a moderate elevation of MDA in the mice lungs.
The results in Fig. 5D show that the increase in the NO level in the test group started as early as 4 h post bacterial infection, and this elevation was significant when compared with that in control groups A, B, and C. The maximum level of NO was seen at 24 h post the second instillation and then it declined gradually. Therefore, these results suggest that the flagellin instillation before bacterial infection stimulated significant production of NO, an important molecule that participates in a nonspecific immune response against any infectious agent. The results of iNOS mRNA expression are presented in Fig. 4 (E and F) . Significant expression of iNOS was seen as early as 1 h post the second instillation when compared with the iNOS expression in all control groups (A, B, C) . The maximum expression of this gene was found at 4 h. Moreover, the significant expression of this gene was also observed in control group B at 4 h after the second instillation.
Phagocytic Activity of Alveolar Macrophages (AMs) In Vitro The activation of AMs plays an important role in the nonspecific restriction of bacterial colonization in the respiratory tract. The AMs isolated from the group of mice instilled with flagellin followed by B. cepacia administration (test group) showed the maximum ability to engulf bacteria in vitro (Fig. 5A) . The results in this figure show the total number of bacteria engulfed by macrophages obtained at different time intervals from the flagellin treated and infected mice. The results showed that the maximum uptake of bacteria was by AMs obtained 4 h post bacterial instillation. A similar trend was also seen with macrophages collected at 24 and 72 h, although the number of engulfed bacteria declined over time. The mice given PBS and bacteria also showed AMs with an enhanced ability, yet the activity was less than that exhibited by the test group macrophages. However, at 72 h, no significant difference was observed between the two groups (test and control group A) as regards the ability of the AMs to engulf bacteria, although the difference was significantly more than that with the other two control groups (B and C) (P<0.05).
A comparison was also made of the killing ability of the AMs obtained from the test and control groups (A, B, and C). The results presented in Fig. 5B show that the maximum bacteria killing was exhibited by the AMs from the test group obtained 24 h post bacterial instillation. This was followed by the results exhibited by the AMs obtained 4 h post bacterial infection, although the number of killed bacteria declined over time. The AMs obtained from the animals given PBS and bacteria (infected but not protected) also showed an enhanced killing ability, although less than that exhibited by the test group macrophages. However, no significant difference was observed in the bacteria killing by the AMs obtained from the mice belonging to either the test or the control group A at 72 h post the second instillation, yet this difference was significantly more when compared with that with the other control groups (B and C) (P<0.05) (Fig. 5B) .
Histopathological Study
To evaluate the effect of the prior instillation of flagellin on the inflammation response and cellular infiltration into the airways, a histological analysis of the lung tissue obtained from test and control groups at different time points was performed. Fig. 6a shows a lung section from a mouse exhibiting interstitial pneumonitis 24 h after infection with B. cepacia. The infection with B. cepacia induced moderate cellular infiltration within the alveolar spaces. Fig. 6b represents a lung section with slight residual inflammation 72 h post bacterial infection (unprotected mice with flagellin). The flagellin treatment before bacterial instillation induced edema as well as moderate infiltration of neutrophil polymorphonuclear leukocytes (PMNLs), affecting only the perivascular and peribronchial regions (Fig. 6d and 6e) . At 72 h, the lungs from the mice that received flagellin and B. cepacia exhibited complete resolution of the inflammation and no drastic collapses (Fig. 6f) . Therefore, these results suggest that flagellin induces a strong but transient inflammatory response that promotes the clearance of bacteria without causing any permanent changes of lung tissue.
Prior Flagellin Instillation Makes B. cepacia Vulnerable to Innate Immune Defenses
To evaluate whether the prior instillation of flagellin contributes to control of the B. cepacia infection in the lungs, the group of mice instilled with 1 µg of flagellin was challenged with bacteria intranasally 4 h post instillation (test group). The results in Fig. 7 show significant (P<0.05) reduction in the bacterial count in the lungs of the test group at different time points (12, 24 , and 48 h) when compared with that for the control group (mice infected with B. cepacia after PBS instillation intranasally). In both cases, the peak bacterial count in the mouse lungs was detected 12 h post bacterial instillation and then rapidly declined. Finally, the infection was almost resolved by 48 and 72 h post bacteria instillation in the test and control groups, respectively. Thus, the detection of flagellin is critical to a robust mouse innate immune response that can control the B. cepacia infection.
DISCUSSION
Innate immunity plays an important role in controlling mucosal infection via the requirements for TLRs and MyD88 to prevent early colonization of the pathogens [1, 45] . Recent studies have revealed that the administration of flagellin activates mucosal innate immunity, which in turn helps to prevent bacterial infection on mucosal surfaces [20, 22, 41] . Accordingly, this study assessed whether exogenous administration of the TLR5 agonist flagellin could strengthen the innate immunity, enabling it to control an infection of B. cepacia. It was found that local administration of flagellin was effective when performed 4 h before the infection establishment in lungs of BALB/c mice.
Many studies have demonstrated that the in vivo administration of flagellin up-regulates the expression of proinflammatory cytokines [10, 16, 21, 34, 35, 43] . In the present study, the administration of flagellin prior to a B. cepacia challenge also up-regulated the expression of IL-1β and TNF-α in the lungs, whereas B. cepacia or flagellin alone induced those genes poorly. Moreover, the prior instillation of flagellin before the bacterial challenge improved the phagocytic activity of AMs in vitro and increased the generation of nitric oxide in vivo. The histopathological study showed a high infiltration of neutrophil PMNLs that reached a maximum 24 h after the intranasal bacterial instillation. The results of the MPO and neutrophil count also confirmed the results of the histopathological study. Thus, when taken collectively, these data indicate that the effect of flagellin on the neutrophil PMNL influx would appear to be a major contributor to the enhancement of bacterial clearance, as neutrophils are the first line of defense against microorganisms and contribute significantly to inflammation [23] . In spite of the high infiltration of neutrophil PMNLs and high level of inflammatory mediates in the lungs of the group of mice treated with flagellin before bacterial infection, the lungs of this group were completely restored 3 days post bacterial instillation. Meanwhile, the lungs of the mice that were not treated with flagellin before B. cepacia infection showed a little inflammation with an abnormal lung architecture. The molecular mechanisms controlling the TLR5 response not only up-regulate proinflammatory genes but also trigger response termination. Therefore, mucosal treatment with flagellin could be considered as a therapy against B. cepacia, enhancing neutrophil infiltration and concurrently limiting inflammation, which merits further evaluation in clinical trials.
The present results also showed that TLR5 signaling is required for the protection induced by flagellin. In the airways, TLR5 is expressed by alveolar macrophages [30] and epithelial cells [19, 31, 32] , suggesting that these resident cells may be key players in the induction of protective innate defenses against B. cepacia upon flagellin treatment. In line with this, studies by Feuillet et al. [10] and Janot et al. [19] suggested that the airway epithelium is the TLR5-activated tissue involved in chemokine production and neutrophil PMNL recruitment in response to flagellated bacteria. On the other hand, murine neutrophils express TLR5 [14, 44] , and thus TLR5 signaling may also activate neutrophil PMNLs directly and enhance their B. cepacia killing capacity. In this study, the synergetic effect of the activation of AMs and neutrophils on B. cepacia clearance from mouse lungs was demonstrated, giving rise to the hypothesis that flagellin induces the phagocytic activity of macrophages and neutrophil PMNLs, thereby developing protection against infection by B. cepacia.
Several studies have already used flagellin to stimulate mucosal innate immunity to help provide protection against bacterial infection [22, 28] . In such studies, the flagellin and bacteria have been administrated together to make the bacteria vulnerable to the innate immune defenses of mouse lungs. Yet, in the present study, it was shown that 
